POMPANO BEACH, Fla., Nov. 13, 2025 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today reported financial results for the third quarter ended September 30, 2025. Recent Business Highlights Achieved 40% growth in product volume quarter-over-quarter Reported positive top-line randomized controlled trial results demo…

You can read the full content here